Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure. This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.
This report contains market size and forecasts of Epinephrine Auto-Injectors in global, including the following market information:
Global Epinephrine Auto-Injectors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Epinephrine Auto-Injectors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Epinephrine Auto-Injectors companies in 2021 (%)
The global Epinephrine Auto-Injectors market was valued at 2223.6 million in 2021 and is projected to reach US$ 3500.8 million by 2028, at a CAGR of 6.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.3 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epinephrine Auto-Injectors include Viatris, Teva Pharmaceutica, Amneal Pharmaceuticals, Kaléo and Novartis Sandoz, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epinephrine Auto-Injectors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epinephrine Auto-Injectors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epinephrine Auto-Injectors Market Segment Percentages, by Type, 2021 (%)
0.3 mg
0.15 mg
0.1 mg
Global Epinephrine Auto-Injectors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epinephrine Auto-Injectors Market Segment Percentages, by Application, 2021 (%)
Under 6 Years Patients
6 to 12 Years Patients
Over 12 Years Patients
Global Epinephrine Auto-Injectors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epinephrine Auto-Injectors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epinephrine Auto-Injectors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Epinephrine Auto-Injectors revenues share in global market, 2021 (%)
Key companies Epinephrine Auto-Injectors sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Epinephrine Auto-Injectors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Viatris
Teva Pharmaceutica
Amneal Pharmaceuticals
Kaléo
Novartis Sandoz